tradingkey.logo
tradingkey.logo
検索

Metagenomi Inc

MGX
ウォッチリストに追加
1.260USD
+0.050+4.13%
終値 07/02, 13:00ET15分遅れの株価
47.44M時価総額
損失額直近12ヶ月PER

詳細情報 Metagenomi Inc 企業名

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Metagenomi Incの企業情報

企業コードMGX
会社名Metagenomi Inc
上場日Feb 09, 2024
最高経営責任者「CEO」Irish (Jian)
従業員数202
証券種類Ordinary Share
決算期末Feb 09
本社所在地5959 Horton St
都市EMERYVILLE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94608
電話番号15108714880
ウェブサイトhttps://metagenomi.co/
企業コードMGX
上場日Feb 09, 2024
最高経営責任者「CEO」Irish (Jian)

Metagenomi Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--

よくある質問

Metagenomi Incの上位5名の株主は誰ですか?

Metagenomi Incの上位5名の株主は以下のとおりです。Dr. Brian C. Thomas, Ph.D.

Metagenomi Inc(MGX)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Metagenomi Incの株式を保有している機関は172社あり、保有株式の総市場価値は約8.82Mで、全体の23.43%を占めています。2025Q4と比較して、機関の持ち株は-6411264.00増加しています。